×

Use of Toll-Like Receptor agonist for treating cancer

  • US 9,376,473 B2
  • Filed: 01/10/2012
  • Issued: 06/28/2016
  • Est. Priority Date: 01/10/2011
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating a cancer that does not express Toll-Like Receptor 5 (TLR5) in a subject in need thereof, comprising administering to the subject an effective amount of a TLR5 agonist,wherein the cancer is present in a liver tissue that expresses TLR5, andwherein the TLR5 agonist is flagellin or a flagellin derivative.

View all claims
  • 5 Assignments
Timeline View
Assignment View
    ×
    ×